On November 18, 2022, Dr. Nielsen Fernandez-Becker, director of the Celiac Disease Program at Stanford Health Care, provided a live presentation on the NIAID-funded study, Solutions for Celiac. The event was co-hosted by the Celiac Community Foundation of Northern California, a nonprofit organization that offers support, education and advocacy.
This webinar-style presentation explained what’s involved in the Solutions for Celiac study, one of several celiac disease clinical trials currently being conducted at the center. The short presentation was followed by a live Q&A session with Dr. Fernandez-Becker and the study team. View the recorded webinar.
Solutions for Celiac is a non-invasive research study for those with celiac disease. It involves an investigational medication in the form of a powdered drink, taken with each meal, and designed to potentially reduce the symptoms of accidental glutening. Participation involves up to 6 visits over a 26-week period. Learn more and sign up: www.SolutionsforCeliac.com/Survey
Dr. Nielsen Fernandez-Becker is the director of the Celiac Disease Program at Stanford and is highly experienced in diagnosis and management of celiac disease and gluten associated disorders. Her objective is to provide excellent and compassionate clinical care for her patients while seeking a better understanding of diseases that she treats, particularly celiac disease (CeD), and eosinophilic esophagitis (EoE). Her top priorities are patient care and translational research to make new discoveries and improve the care of patients.
Contact: Diana Souki, Clinical Research Coordinator Associate, email@example.com
The Celiac Community Foundation of Northern California provides evidence-based support to those with celiac disease and other gluten-related disorders. An all-volunteer nonprofit, it also administers Camp Celiac, facilitates research, and advocates on legislative and regulatory issues.
Information about the Solutions for Celiac study and our foundation’s participation in the webinar are provided as a pro bono public service to help advance research toward a treatment for celiac disease.